Gornitzky & Co. represented the underwriters, led by Morgan Stanley and Jefferies, in the USD 59 million initial public offering of Kamada Ltd. on the NASDAQ Global Select Market.
Kamada, a biopharmaceutical company engaged in specialty life-saving therapeutics, was traded on the Tel Aviv Stock Exchange prior to the NASDAQ offering and its shares are now traded on both the TASE and the NASDAQ.
The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.
